P186D

Claim your 0.5h CE/CME Credit Here
Name*

First NameLast Name
Email*
example@example.com
MD/DORN/NPPAPharmD/RPhRespiratory TherapistNon-Clinician Research CoordinatorOther
medical oncologistsurgical oncologistradiation oncologisthematologistother internisthospitalistprimary care provideremergency medicineOther
NPPICUcath labwardclinicacademicindustryOther
hospital/health system-basedcommunityacademicindustryOther
EU/GBCanadaUSALatin AmericaAustralia/NZAsia
found it on Twitter searching in subject areafound it on twitter searching for CE/CMEfound it on Twitter by following individual influencerfound it on Twitter by following institutional influencerfrom LinkedIn
How many years have you been in practice?
How many patients per month do you typically see with the disease addressed in this tweetorial?
Let's consider a 67y/o AAM, Gleason 9 T3bN1, s/p radical prostatectomy & PLND, 5 nodes+, pre-surgery PSA 26.65; ️post-op 1.29.

Timeline:
ADT+salvage RT 9/2021-12/2021

6/2022 PSA 3.34, testosterone 253

Started abiraterone/prednisone for metastatic HSPC

1/2023 CT increasing nodes, PSAs 6.24, testosterone
a. Offer Lu177 PSMA radioligand therapyb. Switch to another ARSI such as enzalutamidec. Order next generation sequencing, either tissue based or liquidd. Refer for radium 223 therapy
YesNo
YesNo
4. On a scale of 1 to 5, how applicable to your clinical practice was the material in this tweetorial?*

1

2

3

4

5

1 is Not At All Pertinent, 5 is Extremely Pertinent
Not pertinent to my practiceReinforces my practiceMakes me want additional educationWill change my practice
YesNo
MonthDayYear
Date
Title of Course
Should be Empty: